Nanotherapeutic approaches targeting angiogenesis and immune dysfunction in tumor microenvironment

查看全文 作　　者：Sadaf [1]Hameed;Pravin [1]Bhattarai;Zhifei [1]Dai

机构地区：[1]Department of Biomedical Engineering, College of Engineering, Peking University

出　　处：《Science China(Life Sciences)》索引2018年第61卷第4期,共12页

基　　金：supported by National Key Research and Development Program of China (2016YFA0201400);the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81421004) 摘　　要：Tumor microenvironment(TME) comprising cellular and non-cellular components is a major source of cancer hallmarks.Notably, angiogenesis responsible for normal physiological remodeling process can otherwise harness vessel abnormalities during tumorigenesis eliciting severe therapeutic inefficiency. Currently, FDA approved antiangiogenic drugs have only shown modest clinical success owing to tumor hypoxia, antiangiogenic therapeutic resistance, and limited knowledge in understanding TME. In order to overcome these limitations, targeting angiogenesis combined with immunosuppressive TME could offer potential therapeutic opportunities. Indeed, these therapeutic approaches can be further revisited with the advent of nanotechnology that can target the key cellular components of TME and tumor cells more precisely. Synergetic targeting without eliciting systemic toxicity achieved by integration of antiangiogenic and immunotherapy in a single nanoplatform is vital for therapeutic success. In this review, we will discuss the most promising nanotechnological advancements oriented to modulate the immunosuppressive TME in association with antiangiogenic therapy that has gained immense popularity in cancer treatment. 关键词：微型环境免疫力指向肿瘤机能障碍癌症治疗治疗学 TME

相关文献

参考文献（87）
引证文献（7）
耦合文献（62）

参考文献(87)

引证文献(7)

耦合文献(62)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Nanotherapeutic approaches targeting angiogenesis and immune dysfunction in tumor microenvironment

参考文献(87)

引证文献(7)

耦合文献(62)

用户提示